Meet The Disruptors: Dave Hanaman Of Curavit Clinical Research On The Three Things You Need To Shake Up Your Industry

…It would simply be to encourage people who are considering a different path to take the risk of engaging in a new venture. Of course we should plan and prepare, but eventually one simply has to make a leap of faith.

As a part of our series about business leaders who are shaking things up in their industry, I had the pleasure of interviewing Dave Hanaman.

Dave Hanaman is co-founder, president and chief commercial officer of Curavit Clinical Research, a virtual contract research organization (VCRO), that designs and executes decentralized clinical trials (DCT). He is a proven entrepreneur, operator, and board director with successful, strategic exits to public companies. Founder of C3i, a Business Process Outsourcing (BPO) healthcare provider that was sold to a Fortune Global 500 company in 2018, Dave developed and led its sales, marketing, product development, and alliance strategies. Dave serves as a board member and advisor to several start-up and growth-stage companies in healthcare and technology. When not working, he enjoys spending time in the world’s mountains and oceans. He…